What is Middle Meningeal Artery Embolization (MMAE)?

Middle Meningeal Artery Embolization (MMAE) is a non-surgical, catheter-based procedure that targets the middle meningeal artery, a key blood vessel supplying the dura mater — the outer layer of the brain. The goal is to block this artery using embolic materials, thereby stopping the blood supply to the membranes responsible for maintaining the hematoma.

Why is MMAE a Breakthrough for Chronic Subdural Hematomas?

The revolutionary aspect of MMAE lies in its ability to treat the underlying cause of CSDH — persistent vascularization and bleeding from the outer membrane of the hematoma. Traditional surgical methods like burr hole drainage only remove the fluid but don’t address these fragile blood vessels, leading to high recurrence rates. MMAE, however, tackles this issue directly, reducing recurrence and improving long-term outcomes.

Also Read: Top Brain Aneurysm Treatment Doctor in Indore – Dr. Alok Kumar Udiya

Who is Dr. Alok Kumar Udiya?

Dr. Alok Kumar Udiya, a leading interventional neuro-radiologist at CARE CHL Indore, has brought global standards of neuro care to central India. His extensive experience in neurovascular interventions and precision in procedures like MMAE have made him a trusted name among patients and peers alike.

Why Choose CARE CHL Indore for MMAE?

• State-of-the-art facilities for neuro-intervention
• Experienced team led by Dr. Alok Kumar Udiya
• Patient-centered care with post-procedure follow-up
• Excellent success rates for MMAE procedures

CARE CHL Indore is setting a benchmark in neuro care, particularly for advanced, minimally invasive procedures like Middle Meningeal Artery Embolization.

How is MMAE Performed?

1. Vascular Access: A small catheter is inserted, usually via the femoral artery.
2. Catheter Navigation: Under fluoroscopy, the catheter is advanced to the middle meningeal artery.
3. Embolization: Embolic agents such as microparticles or coils are deployed to block the artery.
4. Recovery: Most patients can go home the next day, with minimal discomfort.

Also Read: Best Vascular Surgeon in Indore: Dr. Alok Kumar Udiya

Benefits of MMAE Over Traditional Surgery

Clinical Evidence and Outcomes

Studies across the globe — including research in the New England Journal of Medicine — have shown MMAE to be both safe and effective, especially in reducing recurrence rates of chronic subdural hematomas. In India, Dr. Alok Kumar Udiya’s practice at CARE CHL Indore has mirrored these results with consistently positive patient outcomes.

When Should You Consider MMAE?

You may be a candidate for MMAE if:

• You have a chronic subdural hematoma diagnosed via CT/MRI.
• You’re at high surgical risk due to age or co-morbidities.
• You have a recurring hematoma post-surgery.
• You prefer a non-surgical treatment alternative.

Also Read: 10 Effective Ways to Stop Gangrene from Spreading Quickly

Patient Success Stories at CARE CHL Indore

Many patients treated by Dr. Alok Kumar Udiya at CARE CHL Indore have shared inspiring stories of rapid recovery, zero complications, and restored quality of life following MMAE. These testimonials reflect the life-changing impact of this advanced treatment modality.

FAQs

What is the success rate of MMAE?
MMAE has a success rate of over 90% in treating chronic subdural hematomas, with significantly reduced recurrence.

Is MMAE painful?
No, the procedure is typically performed under local anesthesia and is well-tolerated by patients.

How long does the procedure take?
On average, the MMAE procedure lasts 45 minutes to 1 hour.

Can MMAE be used as a first-line treatment?
Yes, in many cases MMAE is effective as a primary treatment, especially for patients not fit for surgery.

Are there any side effects of MMAE?
Side effects are rare but may include mild headache, dizziness, or local bruising at the catheter site.

How soon can I resume normal activities after MMAE?
Most patients return to daily activities within a week, depending on overall health.

Conclusion

Middle Meningeal Artery Embolization (MMAE) represents a paradigm shift in the treatment of chronic subdural hematomas. With fewer complications, shorter recovery times, and lower recurrence, it offers a safer, smarter alternative to traditional surgery. Thanks to the visionary work of Dr. Alok Kumar Udiya at CARE CHL Indore, patients now have access to one of the most advanced neuro-interventional techniques in India.

Whether you’re a patient, caregiver, or healthcare provider, understanding the benefits and science behind MMAE can empower better decisions and better outcomes.

To learn more or schedule an appointment with Dr. Alok Kumar Udiya, visit CARE CHL Indore today.